GlassScriptPhysician profile
Jill Johnson
NPI 1841073228
$1,190.21
in general payments reported to CMS, 2019-2025
17 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $230 · 2024: $577 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $241.59 | 2024-2025 | Austedo Xr, Austedo Xr |
| Corium, LLC | $235.59 | 2023-2025 | Azstarys |
| Abbvie INC. | $226.41 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $113.36 | 2024 | Qelbree |
| Axsome Therapeutics, INC. | $79.84 | 2023-2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $73.33 | 2023-2024 | Rexulti |
| Alkermes, INC. | $37.98 | 2023 | Aristada, Vivitrol, Lybalvi |
| Neos Therapeutics, LP | $30.65 | 2023 | Adzenys Xr-Odt |
| Neurocrine Biosciences, INC. | $24.31 | 2024 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $20.46 | 2024 | |
| Noven Therapeutics, LLC | $16.69 | 2023 | Xelstrym |
| Idorsia Pharmaceuticals US INC | $16.57 | 2024 | Quviviq |
| Indivior INC. | $16.11 | 2023 | Sublocade |
| Janssen Pharmaceuticals, INC | $15.25 | 2024 | Spravato |
| Lundbeck LLC | $14.56 | 2023 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $14.41 | 2023 | Dyanavel Xr |
| Braeburn INC. | $13.10 | 2024 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.